✦ LIBER ✦

Re: Efficacy of Everolimus in Advanced Renal Cell Carcinoma: A Double-Blind, Randomized, Placebo-Controlled Phase III Trial

✍ Scribed by Stephen H. Culp; Christopher G. Wood

Book ID: 113611376
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 120 KB
Volume: 55
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2009.03.035

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Re: Efficacy of Everolimus in Advanced R

Re: Efficacy of Everolimus in Advanced Renal Cell Carcinoma: A Double-Blind, Randomised, Placebo-Controlled Phase III Trial

✍ Frédéric Pouliot; Allan J. Pantuck 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Efficacy of everolimus in advanced renal

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

✍ Robert J Motzer; Bernard Escudier; Stéphane Oudard; Thomas E Hutson; Camillo Por 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 197 KB

Efficacy and Tolerability of Almotriptan

Efficacy and Tolerability of Almotriptan in Adolescents: A Randomized, Double-Blind, Placebo-Controlled Trial

✍ Steven L. Linder; Ninan T. Mathew; Roger K. Cady; Gary Finlayson; Gary Ishkanian 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

Tanezumab Reduces Osteoarthritic Knee Pa

Tanezumab Reduces Osteoarthritic Knee Pain: Results of a Randomized, Double-Blind, Placebo-Controlled Phase III Trial

✍ Mark T. Brown; Frederick T. Murphy; David M. Radin; Isabelle Davignon; Michael D 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 467 KB

Efficacy and safety of golimumab in pati

Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double-blind, placebo-controlled, phase III trial

✍ Robert D. Inman; John C. Davis Jr.; Désirée Van Der Heijde; Laura Diekman; Joach 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 2 views

## Abstract ## Objective To evaluate the efficacy and safety of golimumab in patients with ankylosing spondylitis (AS) in the GO‐RAISE study. ## Methods Patients with active AS, a Bath AS Disease Activity Index (BASDAI) score ≥4, and a back pain score of ≥4 were randomly assigned in a 1.8:1.8:1

Efficacy and safety of sorafenib in pati

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

✍ Ann-Lii Cheng; Yoon-Koo Kang; Zhendong Chen; Chao-Jung Tsao; Shukui Qin; Jun Suk 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 195 KB